awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33400292-511C6AC1-8191-460D-8040-FAB73D48B31F
Q33400292-511C6AC1-8191-460D-8040-FAB73D48B31F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400292-511C6AC1-8191-460D-8040-FAB73D48B31F
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer
P2860
Q33400292-511C6AC1-8191-460D-8040-FAB73D48B31F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400292-511C6AC1-8191-460D-8040-FAB73D48B31F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f10df62313eb64426499b2aea0db4fcfd3bf280a
P2860
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.